Cost Strategies and Testing Solutions in the COVID-19 Era

This chapter explores the financial aspects of PCR-based COVID-19 testing, highlighting the need for a sustainable reimbursement model and efficient lab operations. It also draws parallels to cancer genomics, advocating for the adoption of insights from that field to enhance testing approaches.